Delivery Order SPE2DB22D1041-SPE2DB25FTZP3

Award Date 2/14/25
Potential Completion Date 2/18/25
Potential Value $3.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,089.38 firm fixed-price delivery order is for the supply of 90-count bottles of 32mg Candesartan Cilexetil tablets. The contract has an ultimate completion date of October 10, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the delivery of 4,566,514,819 units of Candesartan Cilexetil 32 mg tablets. The firm-fixed-price delivery order, valued at $2,264.64, has a completion date of November 22, 2024. The contract is not designated as a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $18,799.28, is for the delivery of 4,566,597,251 tablets of Candesartan Cilexetil 32 mg. The contract is a Firm Fixed Price Delivery Order and has an ultimate completion date of December 4, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp. for the delivery of Candesartan Cilexetil 16 mg tablets. The contract has a ceiling value of $36,318.43 and an ultimate completion date of July 18, 2024. It is a Firm Fixed Price Delivery Order contract, with no set-aside designation. Amerisourcebergen, a major pharmaceutical distributor, will provide these essential medication supplies to support military treatment facilities and federal...
This federal contract award, valued at $23,571.53, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Candesartan Cilexetil 32 mg tablets in 90-count packages. This is a firm fixed-price delivery order contract with a completion date of November 29, 2024. The contract was not set aside for any specific business type. Amerisourcebergen holds a significant...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a Delivery Order valued at $5,803.98 under the Defense Logistics Agency (DLA) Troop Support Medical Indefinite Delivery Contract (IDC) worth up to $999,999,999. The contract is for the supply of 4,565,220,551 tablets of the medication Candesartan Cilexetil 32 mg, with a completion date of July 23, 2024. The contract has a Firm Fixed Price pricing type and is not designated as a set-aside....
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Candesartan Cilexetil 32 mg tablets. The contract, valued at $2,126.36, is a Delivery Order with a Firm Fixed Price pricing type and a completion date of December 11, 2024. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $3,247.80, is for the delivery of Candesartan Cilexetil 8mg tablets. It is a firm fixed-price delivery order contract with a completion date of September 17, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at up...
This federal contract award is for the delivery of 4,566,598,453 units of Candesartan Cilexetil 32 mg tablets in 90-count bottles. The contract was awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,504.01, is a Delivery Order under a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, worth $999,999,999. The IDC serves...
This federal contract award, valued at $7,632.10, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of Candesartan Cilexetil 16 mg tablets, a cardiovascular medication. The contract has an ultimate completion date of October 23, 2024 and was awarded on October 22, 2024. It is a firm fixed-price contract, with no set-aside designation....
  • SPE2DB22D1041
    Indefinite Delivery Contract
  • SPE2DB22D1041-SPE2DB25FTZP3
    Delivery Order

This federal contract award is a delivery order to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the supply of CANDESARTAN CILEXETIL 32 MG TB 90S to the Defense Logistics Agency (DLA). The total ceiling value of the contract is $3,636.47, and it has an ultimate completion date of February 18, 2025. The contract is a firm fixed-price arrangement, and there is no set-aside designation mentioned. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

Generated 5/16/25, 12:17 PM